Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Stanley Hazen
Washington University, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Liposcience, Inc.
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Hazen developed technology that relates to this grant and includes the use of assays for specific gut flora metabolites as potential diagnostic tests for the prediction of cardiovascular risks. The patent application for this technology is titled “Trimethylamine compounds as risk predictors of cardiovascular disease.” Cleveland Clinic and Liposcience, Inc. entered into a license agreement for this technology. The license agreement provides for the receipt of commercialization revenues by Cleveland Clinic. As an inventor, Dr. Hazen is entitled to a portion of the commercialization revenues Cleveland Clinic receives. Therefore, the Cleveland Clinic Innovation Management and Conflict of Interest Program determined that the significant financial interests in the company could directly and significantly affect the design, conduct or reporting of the research.
Lipid Biomarkers for Diabetic Heart Disease
Diabetes is associated with serious cardiovascular complications including heart failure that is unrelated to coronary artery disease. Scientific evidence suggests that blood fat levels play a major role in this complication. Our study will investigate the link between blood fat levels and heart function in adults with type 2 diabetes. Our goal is to develop new blood-based biomarkers of heart disease in diabetics and to provide insight into mechanisms underlying this disorder that will inform new therapeutic strategies.
Filed on May 15, 2013.
Tell us what you know about Stanley Hazen's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Stanley Hazen”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Stanley Hazen | University of California Los Angeles | Conflict of Interest | Cleveland Heartlab, Inc. | $550,000 - $599,999 |
| Stanley Hazen | Cleveland Clinic Lerner Com Cwru | Conflict of Interest | Cleveland HeartLab, Inc. | $250,000 - $299,999 |
| Stanley Hazen | Cleveland Clinic Lerner Com Cwru | Conflict of Interest | Liposcience, Inc. | $20,000 - $39,999 |
| Stanley Hazen | Cleveland Clinic Lerner Com Cwru | Conflict of Interest | Cleveland HeartLab, Inc. | $10,000 - $19,999 |
| Stanley Hazen | Cleveland Clinic Lerner Com Cwru | Conflict of Interest | Cleveland HeartLab, Inc. | $10,000 - $19,999 |
| Stanley Hazen | Washington University | Conflict of Interest | Liposcience, Inc. | $20,000 - $39,999 |
| Stanley Hazen | University of California Los Angeles | Conflict of Interest | Cleveland Heartlab, Inc. | $10,000 - $19,999 |
| Stanley Hazen | Cleveland Clinic Lerner Com Cwru | Conflict of Interest | Cleveland HeartLab, Inc. | $250,000 - $299,999 |
| Stanley Hazen | Tufts University Boston | Conflict of Interest | Cleveland Clinic | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.